Council agenda
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
British Society for Antimicrobial Chemotherapy<br />
<strong>Council</strong> – Thursday 7 July 2016<br />
1230-1530hrs, BSAC, 53 Regent Place, Birmingham, B1 3NJ<br />
AGENDA<br />
INTERACTIVE AGENDA – PLEASE CLICK PAGE NUMBERS TO NAVIGATE<br />
1 Welcome, apologies, future meetings and declarations of interest<br />
Welcome:<br />
Dr Susan Hopkins; Professor William Hope; Dr Carole Fry; Dr Timothy Walsh,<br />
Ordinary Members of <strong>Council</strong><br />
Dr Gavin Barlow – Officer for Stewardship and Surveillance<br />
Via teleconference:<br />
Mark Gilchrist<br />
Apologies:<br />
Professor Kate Gould; Dr Paul Long; Dr Kieran Hand<br />
Future meetings:<br />
2016: Tuesday 11 October<br />
2017: Tuesday 17 January<br />
Tuesday 14 March – SPRING CONFERENCE & AGM, London<br />
Tuesday 11 April<br />
Thursday 6 July<br />
Tuesday 10 October<br />
All meetings to be held 1230-1530hrs at BSAC HQ<br />
Declarations<br />
Trustees are asked to declare any interests they have in any item under discussion<br />
and, where deemed necessary, leave the room during discussion<br />
2 Minutes of the last meeting<br />
To receive the unconfirmed minutes of the meeting held 21 April2016 Pages 4-14<br />
3 Matters arising<br />
4 Finances<br />
Presented by: Honorary Treasurer, Conor Jamieson (unless otherwise stated)<br />
4a<br />
Verbal report on the potential impact of the result of the EU Referendum<br />
1
4b To note the process for approval of the BSAC budget 2016-2017<br />
4c<br />
BSAC investment property, 11 The Wharf, Birmingham – to receive a report on an<br />
approach to purchase Page 15<br />
5 Stewardship and surveillance<br />
5a<br />
Working internationally: Update on collaborations in India, Russia, Africa and China<br />
Presented by: President, Dilip Nathwani OBE<br />
5b<br />
UK OPAT Initiative – to receive a verbal report on discussions held 30 June regarding<br />
re-development of the National Outcomes Registry and Patient Management System<br />
Presented by: Co-chair of the UK OPAT Initiative, Mark Gilchrist<br />
5c BSAC & European Wound Management Association Stewardship Initiative Page 16<br />
6 Education and events<br />
6a e-Learning – to consider a report outlining planned activity and assembly of faculty Page 17<br />
Presented by: President, Dilip Nathwani OBE<br />
6b<br />
To receive a verbal report on a recent meeting held to discuss the future of the FIS<br />
Conference and note the business model proposed by BSAC for 2017 Page 18-20<br />
Presented by: CEO, Tracey Guise<br />
6c FOR INFORMATION: To receive a report on forthcoming BSAC events Pages 21-22<br />
Presented by: Meetings Secretary, Brendan Healy<br />
7 Public Engagement<br />
Presented by: Chair in Public Engagement, Laura Piddock<br />
7a To consider a written report on public engagement activities Pages 23-26<br />
7b To receive a report on the initial meeting of the EURAMET AntiMicroResis Project Page 27<br />
8 Journal of Antimicrobial Chemotherapy<br />
Presented by: Editor in Chief, Peter Donnelly<br />
8a To receive the unconfirmed minutes of the Publication Committee meeting held Pages 28-33<br />
April 2016<br />
2
8b<br />
To receive a verbal report on journal matters<br />
9 Standards/guideline development<br />
Presented by: Executive Officer, Tracey Guise on behalf of General Secretary, Kate Gould<br />
FOR INFORMATION: To receive a position statement on groups in progress Pages 34-35<br />
10 BSAC Funding Programme<br />
To receive the minutes of the meeting of Grants Committee held 11 May and note<br />
outcome of funding considerations Pages 36-41<br />
11 Membership<br />
Presented by: Executive Officer, Tracey Guise on behalf of General Secretary, Kate Gould<br />
To consider nominations for election to Membership of the Society Page 42<br />
12 Any other business<br />
3
British Society for Antimicrobial Chemotherapy<br />
Unconfirmed minutes if the meeting of BSAC <strong>Council</strong><br />
held Thursday 21 April 2016<br />
Present:<br />
Co-opted:<br />
In attendance:<br />
Professor Dilip Nathwani OBE (Chair)<br />
Dr Nicholas Brown, Vice President<br />
Dr Conor Jamieson, Honorary Treasurer<br />
Mr Mark Gilchrist, Ordinary Member<br />
Enrique Castro-Sanchez – Ordinary Members of <strong>Council</strong><br />
Dr Natasha Ratnaraja, Ordinary Member<br />
Dr Sanjay Patel, Ordinary Member<br />
Professor Peter Donnelly, JAC Editor in Chief<br />
Professor Laura Piddock, Chair in Public Engagement<br />
Dr Cliodna McNulty, Co-opted member<br />
Mr Colin Drummond, Editorial Manager<br />
Mrs Tracey Guise, Chief Executive Officer<br />
Apologies:<br />
Professor Kate Gould, General Secretary<br />
Dr Gavin Barlow – Officer for Stewardship and Surveillance<br />
Dr Brendan Healy, Meetings Secretary<br />
Dr Paul Long, Grants Secretary<br />
Dr Tamara Schneider, Ordinary Member<br />
Professor Andrew Pearson, Co-opted<br />
Dr Timothy Walsh, Ordinary Member<br />
Professor William Hope, Ordinary Member<br />
Dr Sanjay Patel, Ordinary Member<br />
C/16/15<br />
Welcome and apologies for absence<br />
The Chair welcomed members to the meeting, in particular Dr Sanjay Patel in attendance for the<br />
first time. Apologies for absence were NOTED.<br />
C/16/16<br />
Future meetings<br />
2016: Thursday 7 July; Tuesday 11 October<br />
All meetings to be held 1230-1530hrs at BSAC HQ<br />
4
C/16/17<br />
Declarations of interest<br />
There were no declarations of interest in the business listed for transaction at the meeting.<br />
C/16/18<br />
Minutes of the last meeting<br />
The unconfirmed minutes of the meeting held 20 January 2016 were APPROVED and SIGNED as a true<br />
record subject to one amendment.<br />
C/16/19<br />
Matters arising<br />
There were no matters arising not dealt with elsewhere at the <strong>agenda</strong>.<br />
C/16/19a<br />
C/16/08a BSAC Drugs Stability Testing Programme<br />
<strong>Council</strong> was reminded that at the last meeting a proposal to establish a BSAC Drug Stability Testing<br />
Programme was considered, with a request that BSAC underwrite the programme with a proviso<br />
that the programme is self-funding within 2 years. A number of questions were raised by <strong>Council</strong><br />
which had been addressed. A final proposal had been circulated to <strong>Council</strong> by email and majority<br />
approval for the project had been received.<br />
<strong>Council</strong> NOTED the following:<br />
(a)<br />
The purpose and objective of the Programme is to provide evidence on the efficacy and<br />
stability of agents and devices used in the OPAT arena. The benefits of the Programme will<br />
be to make available, open access stability data that will inform practice and has the ability<br />
to improve patient safety and patient outcomes within a rapidly expanding area of<br />
infection management. The Programme objectives are cognisant with the charitable<br />
objectives of the Society “To support the acquisition and dissemination of knowledge in the<br />
field of antimicrobial chemotherapy”.<br />
(b)<br />
The decision to request establishment of the Programme followed a comprehensive<br />
literature review of published evidence on drug stability of antimicrobial agents. This<br />
review, which has accepted for poster presentation at ECCMID 2016, demonstrated a total<br />
absence of published data in the field.<br />
(c)<br />
Agreement is, subject to confirmation of matching funds from commercial sources for Year<br />
1 activity, to underwrite the start-up costs from investments within a range of £40k-£80k<br />
to enable testing and publication of stability data for between 2 – 4 devices and agents.<br />
5
(d) The programme will be subject to review at the end of 2017.<br />
C/16/20<br />
Finances<br />
C/16/20a<br />
Management and governance letter<br />
<strong>Council</strong> RECEIVED copies of the Management and Governance letter from the auditors<br />
appertaining to the accounts for the period 1 October 2014-30 September 2016. The purpose of<br />
the letter is to set out for Trustees/Directors the significant matters which came to the attention of<br />
the auditors during the course of their audit of the financial statements of British Society for<br />
Antimicrobial Chemotherapy (the “Charity”) for the year ended 30 September 2015. The auditors<br />
were present on site to test accountancy systems and procedures from 16-18 February inclusive.<br />
The letter was issued in accordance with the International Standard on Auditing (UK and Ireland)<br />
260, Communication of audit matters.<br />
Members were pleased to NOTE that there were no recommendations for improvement or items of<br />
concern, significant or otherwise were noted or raised during the course of the audit.<br />
C/16/20b<br />
BSAC Resistance Surveillance Programme<br />
The Honorary Treasurer reported that the financial position with regards to the BSAC Resistance<br />
Surveillance Programme for the year 2016 had improved. Four sponsors have now signed for the<br />
year 2016, reducing the overall project deficit to £25,664.95. The Standing Committee is<br />
continuing to work on the business model to ensure the programme is cost-neutral, including<br />
taking account of service costs provided by Southmead Hospital (salaries) from 2017 onwards.<br />
C/16/21<br />
Grants<br />
<strong>Council</strong>:<br />
(a)<br />
APPROVED amendments to the criteria for applicants applying for BSAC grants. The criteria<br />
for the 2016 call will read:<br />
“BSAC encourages applications on topics consistent with the strategy of this Society, and<br />
from early career researchers and clinical trainees. Furthermore, we support proof of<br />
principle research projects which will facilitate applications to other funding agencies.<br />
Please note that we do not encourage applications from those who have been in receipt of<br />
total research funding of more than £100,000 (or equivalent currency of applicant’s<br />
country) in the last 2 years.<br />
6
Each year, BSAC typically awards 1- 2 grants of £50,000 per project (large grant) and 2-3<br />
smaller grants of £15,000 per project. Due to the large number of applications received by<br />
BSAC, there is a triage process where the eligibility of applicants and topic of Application is<br />
assessed. Applications that do not meet these eligibility criteria will be rejected.”<br />
(b)<br />
AGREED to:<br />
i) Focus the call for BSAC grants to areas more closely aligned to the current priorities<br />
and activities of BSAC. Members of <strong>Council</strong> will submit, by Wednesday 18 May,<br />
suggestions for named calls. A final shortlist will be circulated for approval on<br />
Friday 20 May 2016, with the call for 2016 applications opened from June 2016<br />
onwards for award in 2017.<br />
ii) Extend, from the 2016 call onwards, the definition of studentship beyond PhD<br />
studentships to include research training leading to other equivalent awards e.g.<br />
Pharm D, MD, DDS. Funding for a maximum of £25,000pa for a maximum of four<br />
years will remain unchanged.<br />
C/16/22<br />
Stewardship and surveillance<br />
C/16/22a<br />
Use of antibiotics … policy statements<br />
<strong>Council</strong> approved the BSAC policy statements entitled The use of antibacterials in animals and The<br />
use of antibiotics in people.<br />
C/16/22b<br />
BSAC PPS system<br />
<strong>Council</strong> RECEIVED a written report on the BSAC National Antimicrobial Stewardship Point<br />
Prevalence Survey System (NAS-PPS) www.nas-pps.com software tool. The following points arising<br />
were NOTED:<br />
(a)<br />
The software is hosted on a secure N3 NHS governance compliant server environment and<br />
will be available to all UK Trusts and Boards free of charge. In return Trusts and Boards will<br />
share anonymised results via a NAS-PPS dashboard. The system will comprise of two parts:<br />
<br />
<br />
Antimicrobial module (already built, funded by BSAC)<br />
HAI module (under development, funded by PHE, development led by Susan Hopkins<br />
and team)<br />
(b)<br />
Both modules have been / will be built using the latest ECDC datasets, ensuring full<br />
compliance with European data collection. Trusts and Boards will be able to conduct local<br />
surveys, or wider surveys on collaboration with other Trusts and Boards to review<br />
prescribing and aid the design of interventions to improve appropriate prescribing. Trusts<br />
7
will be able to request bespoke PPS templates using the national data set + add in their own<br />
questions. A new template will be required for each bespoke PPS and the estimated cost of<br />
development is up to 4 development days or £2,000 per template. Two options will be<br />
available:<br />
<br />
<br />
Trust to underwrite the cost and keep data locally.<br />
BSAC, if it considers template of value to other Trusts and subject to available funding,<br />
to underwrite the cost and make template available to all Trusts free of charge with the<br />
proviso that centres using centrally funded templates allow notification of the survey<br />
and results via the national dashboard (i.e. allow publication of results by BSAC).<br />
(c)<br />
Public Health England has adopted the NAS-PPS to submit data For the 2016/2017 ECDC<br />
Point Prevalence Survey in acute care hospitals. Once the national data collection is<br />
completed, BSAC will deploy the NAS-PPS across all Trusts and Boards in the UK for use as<br />
training and benchmarking tool.<br />
C/16/22/c<br />
Working internationally: India, Russia, Africa and China<br />
The President reported on the range of international educational and stewardship activities that the<br />
Society is currently leading and working on. <strong>Council</strong> NOTED the following:<br />
(a)<br />
India: The report of the project Reducing Antimicrobial Resistance (AMR) in Indian<br />
Hospitals in support of the PM’s Global Campaign against AMR funded by the Foreign and<br />
Commonwealth Office (FCO) Prosperity Fund has now been submitted to the FCO. The<br />
overall objective was to support India in implementing Global and National strategies [e.g.<br />
Chennai declaration] on tackling AMR with particular reference to education in relation to<br />
antimicrobial prescribing. The report has scoped the requirement for educational solutions<br />
for Indian hospitals to enable development and implementation of such interventions that<br />
culturally and contextually relevant sand will help reduce AMR rates. The President and<br />
CEO will discuss next steps with the FCO and report back to the next meeting.<br />
(b)<br />
Russia: BSAC attended and supported production of a post event website for the high-level<br />
roundtable on policy, research, and collaboration in the field of AMR organised between the<br />
UK and Russia by the UK Science & Innovation Network (SIN)-Russia of the British Embassy<br />
in Moscow and the Interregional Association for Clinical Microbiology and Antimicrobial<br />
Chemotherapy (IACMAC) in Smolensk (Russia). The meeting was held 17-18 December<br />
2015 and brought together leaders from Russian and UK medical science, innovation<br />
funders, along with academies, government departments and business to forge closer links<br />
and to promote mutual understanding of each other’s organisations, research landscapes<br />
and priorities. BSAC has submitted an application to the FCO to support a project similar to<br />
8
that undertaken in India. Website: http://www.bsac.org.uk/uk-russia-roundtablediscussion-antimicrobial-resistance-amr-dialogue-between-sectors/<br />
(c)<br />
Africa: BSAC is working with the Infection Control Africa Network (ICAN) on a project to<br />
develop a curriculum framework for antimicrobial stewardship training for African<br />
healthcare facilities. The Society will co-host a session at the 6 th ICAN Conference to be<br />
held 26-28 September, Johannesburg, at which preliminary data from an online survey<br />
will be presented. Further information: http://ican-ams.com/<br />
C/16/22d<br />
Translation of the Massive Open Online Course on Antimicrobial Stewardship<br />
The President reported that BSAC is seeking to secure funding to support translation of the Massive<br />
Open Online Course on Antimicrobial Stewardship into Spanish, Chinese, and Russian. There has<br />
also been interest in translating the course into Brazilian Portuguese.<br />
C/16/23<br />
Education and events<br />
C/16/23a<br />
BSAC virtual learning platform<br />
<strong>Council</strong> RECEIVED a report on the establishment of the BSAC Virtual Learning Environment and<br />
NOTED the following points arising:<br />
(a)<br />
The platform is aimed primarily at healthcare professionals, researchers and scientists and<br />
will over time provide a range of e-learning modules which will be a mix of open access<br />
and paid for courses. The aim is to offer courses open access to members as a membership<br />
benefit wherever possible. Funding has been secured to develop and offer the following<br />
modules as an opening offer:<br />
<br />
<br />
<br />
<br />
Behavioural science into practice: 6 short modules (Peter Davey leading<br />
Antifungal stewardship<br />
IV to Oral Switch<br />
Use of Oral agents in OPAT settings<br />
(b)<br />
Consideration is being given to development of a non-facilitated course based on the<br />
current MOOC, but with less and new content.<br />
(c)<br />
Each course will be developed using the following expert faculty and management model:<br />
<br />
<br />
<br />
2-3 lead authors/contributors<br />
Peer review panel (General Secretary + 2 identified, suitably experienced individuals per<br />
module)<br />
Dedicated project manager: Sally Bradley<br />
9
Technical support and designer: Neil Watson<br />
Filmed production engineer: Lester Millbank<br />
Evidence review / literature search / supplementary resources: Abi Jenkins<br />
Timescale: 12 -20 weeks per module from securement of faculty<br />
(d)<br />
The aim is that the programme is cost-neutral to the Society, with the ideal being for an<br />
ongoing modest surplus to be available to support platform costs. Based on 1,000 learners<br />
the subscription costs to the v-learning platform will be £10.00 per learner. BSAC has<br />
negotiated a set-up and start-up contract for an initial 6 months after which we will<br />
evaluate usage and negotiate a subscription rate for the next 12 months.<br />
(e)<br />
Development costs per module will vary, but for those supported using external funds costs<br />
will be full economic costs less 50% overheads, this being the Society’s investment and<br />
contribution to development.<br />
(f)<br />
Funding via grants or e-commerce arrangements will be managed by Tracey Guise, CEO in<br />
consultation with Officers and members of <strong>Council</strong> as appropriate. E-commerce will<br />
include the following:<br />
<br />
<br />
<br />
Payments for courses<br />
Payment for courses as part of an event (e.g. v-learning module either supporting or<br />
following workshop)<br />
Purchase credits for bundles of courses/multiple access for group of users (open to<br />
Trusts/Sponsors)<br />
(g)<br />
To date the Society has secured 2 educational grants to a total value of £30,000 to support<br />
development of the modules detailed under heading ‘CONTENT’ and are in late stage<br />
negotiations to secure a further educational grant to support development of a module on<br />
the role of vaccines in reducing AMR.<br />
C/16/23b<br />
Forthcoming BSAC events<br />
<strong>Council</strong> RECEIVED copies of a document outlining details of the following forthcoming BSAC events:<br />
<br />
<br />
<br />
<br />
25-27 April & 23-25 August 2016, BSAC Susceptibility Testing Residential Workshops,<br />
University Hospital of Wales, Cardiff<br />
19 May, BSAC AMR Roundtable Series 2, The Wellcome Trust London UK<br />
11-13 May 2016, 26th Conference of the European Wound Management Association, Bremen,<br />
Germany. Joint BSAC/EWMA Session: Wednesday 11 May<br />
16 June 2016, Proposed meeting on Locally Administered Antibiotics, one day meeting at Royal<br />
College of Physicians, London<br />
10
22 June and 12 October 2016, BSAC Susceptibility Testing User Training Days, London and<br />
Manchester<br />
23 - 25 August, BSAC Susceptibility Testing Residential Workshops 2015, University Hospital of<br />
Wales, Cardiff<br />
October – December, BSAC/BIA/HIS Regional Educational Workshops 2015, Venues across the<br />
UK<br />
FIS/HIS 2016 6 – 8 November, Edinburgh - BSAC sessions are now confirmed as follows:<br />
o PLENARY SESSION, Monday 7 November. 09:00-10:00: Therapeutic and technological<br />
advances in infection management (BSAC Plenary)<br />
o PARALLEL SESSION, Monday 7 November, 10:45-11:15: BSAC Antibacterial resistance<br />
in the British Isles Update for 2016<br />
o PARALLEL SESSION, Tuesday 8 November, 13:30-15:00<br />
<br />
<br />
<br />
8 – 9 December 2016, OPAT Meeting, International Convention Centre Birmingham, UK<br />
European Summit on Vaccines and Diagnostics, 8-9 June 2017, ICC, Birmingham<br />
Federation of Infection Societies 2017, 30 November – 1 December, ICC, Birmingham<br />
C/16/24<br />
Public Engagement<br />
<strong>Council</strong>:<br />
(a)<br />
RECEIVED copies of a report on public engagement activities conducted via Antibiotic<br />
Action for the period 9 th January to 6 th April 2016, Antibiotic Action including details of<br />
publications, responding to media enquiries presenting and/or attending meetings and<br />
conferences. Full details can be found in appendices 1-2.<br />
(b)<br />
AGREED to give consideration to questions to ask APPG members to consider for<br />
presentation as parliamentary questions, and email Professor Laura Piddock, Chair in Public<br />
Engagement with suggestions.<br />
(c)<br />
CONSIDERED and APPROVED IN PRINCIPLE the production of regular (quarterly proposed)<br />
BSAC newsletters to better inform the membership and external stakeholders about the<br />
activities of BSAC. Options for layout of newsletter will be presented to the next meeting.<br />
(d)<br />
NOTED a report of the IMPACT review 3rd stakeholder meeting on which Philip Howard<br />
represents the Society.<br />
C/16/25<br />
Journal of Antimicrobial Chemotherapy<br />
11
The Editor in Chief gave a verbal report on matters appertaining to the strategic and operational<br />
aspects of the JAC, including a report on the meeting of Publications Committee held 20 April<br />
2016. In relation to this report <strong>Council</strong>:<br />
(a)<br />
NOTED the resignation of Leonard Leibovici as Senior Editor to take up the position of Editor<br />
in Chief for CMI and David Reeves leave of absence for personal reasons.<br />
(b)<br />
APPROVED the appointment of John Perry, Engeline Van Duijkeren and Athanassios Tsakris<br />
as Senior Editors and Diane Ashiru-Oredope, Russell Lewis, David Van Duin, Sally Partridge,<br />
Anouk Muller and David Jenkins as Editors.<br />
(c)<br />
SUPPORTED a proposal to increase use of the services of the OUP virtual editorial office<br />
from 40-80 hours per month to assist the BSAC editorial office, noting this as an efficient<br />
and cost effective way to manage the growing workload within the office without<br />
increasing staffing numbers.<br />
C/16/26<br />
Guideline development<br />
A document outlining the guideline working and development groups in progress was<br />
CONSIDERED. <strong>Council</strong> NOTED the following activity:<br />
(a)<br />
BSAC / Vascular Society Vascular Graft Infections Guideline Working Group<br />
Lead: Jon Sandoe (BSAC lead) & Rachel Bell (Vascular Society lead) and Nick Price.<br />
Literature review and data extraction is on-going. Currently only three papers have met<br />
inclusion criteria. Plan to write-up literature search and then identify suitable individuals<br />
willing to sit on a panel for development of a guideline based on expert opinion.<br />
(b)<br />
BSAC, HIS, IPS and BIA MRSA Guideline Working Group<br />
Overall Lead: Irwin Brown, BSAC Lead: Nick Brown<br />
A joint group comprising representation from BSAC, HIS, BIA and IPS has been established<br />
to consider updating the joint BSAC, HIS, ICNA MRSA guidance published 2005/6/8. BSAC<br />
will be working with BIA on treatment and management whilst HIS and IPS will be taking<br />
diagnosis, screening, infection prevention and control aspects forward. Following agreement<br />
on the guideline finances literature search and review is anticipated to begin in early May.<br />
(c)<br />
BSAC, HIS, BIA Joint Guideline Development Group on MDR Gram Negative Infections<br />
Chairs: Peter Hawkey and Peter Wilson<br />
The infection control paper was published in JHI in November. The diagnosis and<br />
treatment paper has been received and will be subject to a process of national consultation<br />
during May-June. BSAC has been asked to provide support in preparing the final<br />
12
manuscript for submission; the CEO is considering what resource might be available to<br />
support this request.<br />
(d)<br />
Therapeutic Monitoring Literature Review Group<br />
Chair: Nick Brown; Authors: Abi Jenkins, Alison Thomson, Yvonne Semple, Nick Brown, Christine<br />
Sluman, Alastair MacGowan, Andrew Lovering and Phil Wiffen<br />
Details of the literature review were presented at the BSAC Spring Meeting and the survey as a<br />
poster at ECCMID. Guideline development meeting (expert opinion) will take place in May.<br />
(e)<br />
OPAT: Oral Agents in the OPAT Setting<br />
Lead: Matthew Dryden<br />
Literature search complete and intend to write-up finding for submission to JAC in the autumn.<br />
(f)<br />
Endocarditis<br />
BSAC guidelines were published in 2011 and following update of guidance produced by other<br />
organisations we aim to update the literature search and review in June 2016. New<br />
evidence will be submitted to the authors for review and consideration of a guideline update.<br />
C/16/27<br />
Membership<br />
16 applications for Membership of the BSAC have been received since the last meeting of <strong>Council</strong>. All<br />
applicants submitted supporting statements which have been seen and verified by the General<br />
Secretary.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Dr Poonam Kapila, Consultant Microbiologist, Kings Mill Hospital<br />
Dr Gereltuya Dorj, Lecturer, Mongolian National University of Medical Sciences<br />
Dr Sharon Sheehan, Consultant Microbiologist, Eastbourne District General Hospital<br />
Dr Blaise Bougnom, Marie Curie Research Fellow, University of Birmingham<br />
Dr Gwenan Knight, Career Development Fellow, Imperial College London<br />
Ms Marisa Pinto, Student Researcher, University of Porto<br />
Mr Neil Powell, Antimicrobial Pharmacist, Royal Cornwall Hospital<br />
Dr Julia Vasant, Medical Microbiology ST5, Southmead Hospital<br />
Mrs Sarah May, Advanced Pharmacist – Antibiotics, Calderdale Royal Hospital<br />
Miss Alessandra Oliva, Infectious Diseases Specialist, Sapienza University of Rome<br />
Mrs Fatma Erdem, MD, Istanbul University<br />
13
Mr Stephen Kidd, Trainee Clinical Scientist, Basingstoke & North Hants Hospital<br />
Dr Kieran Clarke, Global Product Director, Alere<br />
Dr Sulman Hasnie, Consultant Microbiologist, Bradford Royal Infirmary<br />
Dr Virginia Ramos-Martin, Clinical Research Fellow, University of Liverpool<br />
Miss Neha Malhotra, PhD Senior Research Fellow, CSIR-IMTEC<br />
C/16/28<br />
Any other business<br />
There being no further items of business not dealt with elsewhere at the <strong>agenda</strong>, the meeting was<br />
declared closed.<br />
Signed:<br />
…………………………………………………………………..<br />
Date:<br />
…………………………………………………………………..<br />
Meeting of Directors of BSAC Ltd<br />
The Chair convened a meeting of the Directors of BSAC Ltd who adopted all discussion and agreements recorded<br />
above.<br />
14
BSAC Investment Property, 11 The Wharf, Birmingham B1<br />
A document for <strong>Council</strong> to consider<br />
1 Background<br />
BSAC owns a leasehold property at 11 The Wharf, Birmingham B1. There are 971 years remaining on lease.<br />
The property is currently valued at £280,000 (due for revaluation at 30 September 2016). The property<br />
served as the BSAC HQ until 2008 when the Society moved to 53 Regent Place having agreed a provisional<br />
sale price for 11 The Wharf of £1 million + to a development company, with all owners on The Wharf<br />
complex having secured similar agreements.<br />
Plans fell through due to the advent of the recession and the Society decided to seek a tenant. The property<br />
currently attracts a rental income of £20,000 pa, giving an investment yield of 7.14%.<br />
2 Current position<br />
BSAC has received an approach from Mike Gohan, HCB solicitors from an unnamed client asking if we<br />
would be willing to sell the property, for what price and to state the duration of lease remaining. Having<br />
sought the views of Executive Committee the CEO sent a holding reply as follows:<br />
Thank you for your email. I will take this to the Board of Directors for consideration.<br />
I anticipate the Board would be looking to negotiate rates in line with those previously quoted when<br />
redevelopment was last on the cards (the reason we relocated before plans were shelved due to the<br />
recession).<br />
It would be helpful if your client could indicate what uplift on market value (if any) they anticipate as an<br />
opening basis for negotiation.<br />
There is little advantage in BSAC offering a sale price at this stage. The property at 11 The Wharf (which is<br />
situated near the Hyatt Hotel off Broad Street) is giving us a good return on investment and indications are<br />
that commercial property prices in Birmingham are climbing. It is a prime site on the canal front with 3<br />
storey buildings in an area now comprising primarily 10-18 storey mixed commercial, retail and residential<br />
properties. British Waterways had already entered negotiations to lease the waterfront and sell the James<br />
Brindley public house adjacent to The Wharf complex in 2008. It is highly likely that we will receive a<br />
formal approach from a large scale developer in time.<br />
3 Action<br />
<strong>Council</strong> is asked to consider supporting ‘No action’ at the current time but to maintain a watching brief at<br />
this stage.<br />
Conor Jamieson<br />
Honorary Treasurer<br />
June 2016<br />
15
BSAC / European Wound Management AMR Collaborative<br />
A paper for <strong>Council</strong> to consider<br />
1 Background<br />
Following exploratory discussions at ECCMID 2014 in Barcelona, BSAC and the European Wound<br />
Management Association (EWMA) formally launched a joint antimicrobial stewardship collaborative at the<br />
25th Conference of the EWMA held 13-15 May at Excel, London. The collaborative was launched at a joint<br />
session at the conference and was oversubscribed, attracting 400 participants, with many more unable to<br />
gain entry. The 2 societies also collaborated on a joint session at the 2016 EWMA Conference, 11-13 May,<br />
Bremen, Germany.<br />
2 BSAC/EWMA Working Group<br />
A short-lived working group was established to develop a joint position paper on antimicrobial stewardship<br />
in would management. The paper Antimicrobial Stewardship in Wound Care: A British Society of<br />
Antimicrobial Chemotherapy/European Wound Management Association Position Paper has been submitted<br />
and is currently being considered for free access publication by the Journal of Antimicrobial Chemotherapy.<br />
3 Proposals for future collaboration<br />
The collaboration has been valuable, pragmatic and productive and the proposal is that the two societies<br />
continue and extend their collaboration as follows:<br />
<br />
<br />
<br />
<br />
<br />
EWMA, 2017 Amsterdam: Collaborate on development of a paper on non-antibiotic antimicrobials for<br />
wound management (Rose Cooper is working on this with EWMA).<br />
Joint dissemination of outcomes of each society’s publications.<br />
Development of joint e-learning modules.<br />
Working with EWMA in discussing AMR policy based on the Dutch AMS policy, brining UK policy to the<br />
fore also.<br />
Possible joint stand-alone educational events going forward if need is evident.<br />
4 Action<br />
To consider the above proposals and offer comment and additional suggestions for collaboration.<br />
Dilip Nathwani<br />
President<br />
June 2016<br />
16
BSAC Virtual Learning Environment<br />
A document for <strong>Council</strong> to consider<br />
Since the last meeting of <strong>Council</strong> BSAC has continued with the development of the BSAC Virtual Learning<br />
Environment (VLE), a platform aimed primarily at healthcare professionals, researchers and scientists. The VLE<br />
will house a range of e-learning modules which will be a mix of open access and paid for courses, being offered<br />
open access as a membership benefit whenever possible.<br />
To date BSAC has identified and/or secured funding for development of the following modules:<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Behavioural science into practice: 3 short modules - led by Peter Davey<br />
TARGET – Webinar series for GPs, supported by PHE and led by Cliodna McNulty (7 webinars)<br />
GNB infections – led by Lilian Abbo, USA<br />
Vaccines<br />
Antifungal stewardship<br />
IV to Oral Switch<br />
Use of Oral agents in OPAT settings<br />
Proposals are also being developed for a module on optimal use of laboratory diagnostics and role of rapid<br />
diagnostics and development of an e-learning Book on antimicrobial stewardship.<br />
As reported at the last meeting, each course will be developed using the following expert faculty and management<br />
model:<br />
2-3 lead authors/contributors<br />
Peer review panel (General Secretary + 2 identified, suitably experienced individuals per module)<br />
Dedicated project manager: Sally Bradley<br />
Technical support and designer: Neil Watson<br />
Filmed production engineer: Lester Millbank<br />
Evidence review / literature search / supplementary resources: Abi Jenkins<br />
Timescale: 12 -20 weeks per module from securement of faculty<br />
ACTION:<br />
Nominations and suggestions are sought from <strong>Council</strong> for lead authors, contributors and peer review panellists for<br />
the above topics or other topics within the antimicrobial chemotherapy arena.. In the majority of modules<br />
honoraria will be available to recognise the contribution of lead authors and contributors. Self-nominations are<br />
permitted.<br />
Dilip Nathwani<br />
President<br />
June 2016<br />
17
Federation of Infection Societies Conference 2017<br />
28 November – 1 December, International Convention Centre, Birmingham<br />
Business and organisational model<br />
A document for <strong>Council</strong> to consider<br />
1 Objectives<br />
To:<br />
A<br />
Deliver a high quality, cost-neutral conference that enables all FIS member organisations to participate in<br />
the organisation of plenary and parallel sessions with all costs for the main programme met from<br />
Conference income.<br />
B<br />
Pilot an alternative business and organisational model that might inform forward arrangements and allow<br />
for any FIS member organisation, regardless of its size or financial capabilities, to lead on organisation of the<br />
annual FIS conference, offering equitable basis to all.<br />
2 Host Society 2017<br />
BSAC will be host Society and will be responsible for contracting with the conference provider and chairing<br />
and organising meetings of the Scientific Organising Committee.<br />
3 Conference Organiser 2017<br />
A commercial conference organiser has been contracted to deliver and underwrite all financial and<br />
operational risks for the following:<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
A multi-session conference for 700+ delegates over 3 days with catering and refreshment breaks.<br />
All costs associated with the conference programme, including speaker costs<br />
Provision of exhibition area for FIS bodies at no cost other than graphic panel production<br />
Securing of commercial sponsors/exhibitors<br />
Promotion of the event, delegate registrations and management of finances for the conference.<br />
Provision and maintenance of the FIS Conference website.<br />
Publication of all slide sets and abstracts for the event on the Conference website within 21 days of the<br />
Conference ending<br />
18
4 Business model<br />
<br />
<br />
<br />
<br />
<br />
The fee for the conference organiser will be 50% of all sponsorship raised.<br />
Conference costs will be managed in full by the conference organiser with delegate fees and 50% of<br />
sponsorship being used to cover all conference costs (venue, catering, insurances, speaker expenses<br />
including travel and hotel accommodation, printing, website, conference app, exhibition build, and other<br />
associated costs)<br />
BSAC will receive a project management fee equivalent of 5% of total delegate income as a contribution<br />
towards staffing costs and overheads.<br />
The conference organiser will bear the cost of any losses incurred.<br />
Any surplus after the deduction of all costs will be paid back to the host Society, BSAC, for disbursement on<br />
the next FIS Conference as grants for trainees or for whatever common purpose the FIS organisations might<br />
choose.<br />
5 Programme development<br />
<br />
<br />
<br />
The Scientific Organising Committee (SOC), comprising one representative, or their alternate, from each FIS<br />
organisation, will develop the programme.<br />
BSAC will chair and administer the SOC including securing or assisting in securing speakers.<br />
Members of the Scientific Organising Committee will receive a full conference registration.<br />
6 Return on investment to organisations participating in FIS:<br />
<br />
<br />
Participation at no cost for all plenary and parallel sessions – all speaker costs covered in accordance with<br />
the conference expenses policy.<br />
Standard exhibition space and branded external stand wall (visual to be provided). Inside wall to contain<br />
standard size graphic designed by individual societies<br />
7 Costs to organisations.<br />
<br />
<br />
Organisations hosting named lectures and lunches will be responsible for the costs associated with these.<br />
Organisations can request to host workshops or events outside of the main conference programme.<br />
Permission will be granted if there is capacity available and these events are in line with the ethos of the<br />
conference / do not compromise attendance at the main conference sessions. The organising body must<br />
meet the cost for any additional workshops, including room hire, catering and speaker expenses.<br />
8 Conference expenses policy<br />
19
A<br />
This expenses policy relate to chairs and speakers from within the UK only for the core programme.<br />
Organisations wishing to nominate speakers from outside the UK will be responsible for their full travel<br />
costs minus a contribution of £150.00 from conference.<br />
B<br />
Individuals presenting posters, free papers and clinical lessons will not be supported by conference and will,<br />
as in previous years, be required to register and meet their own travel and accommodation expenses.<br />
C<br />
All speakers will receive:<br />
<br />
<br />
<br />
Full conference registration<br />
One night accommodation in the chosen speaker hotel(s) for each day they are presenting at the conference.<br />
Standard class travel (flight or train booked at the earlies opportunity possible, and no later than one month<br />
in advance) or 0.45p per mile for travel by car where travelling by car is more economical than travelling<br />
by rail<br />
D<br />
All session chairs will receive full conference registration and travel expenses only.<br />
E<br />
All Members of the organising committee will receive full conference registration only.<br />
F<br />
Expenses for speakers giving named lectures, and all hospitality associated with such, will be met in full by<br />
the organising body.<br />
G<br />
Expenses for any workshops or sessions organised outside the main conference programme will be met in<br />
full by the requesting organisation.<br />
H<br />
There will be no exceptions to the above policy. Requests for travel and accommodation that exceed the<br />
conference expenses policy must be approved by the host organisation that will be invoiced for these costs.<br />
Tracey Guise<br />
BSAC Chief Executive<br />
On behalf of BSAC<br />
May 2016<br />
20
Forthcoming BSAC Meetings<br />
A document for <strong>Council</strong> to note<br />
23 - 25 August, BSAC Susceptibility Testing Residential Workshops 2015, University Hospital of Wales, Cardiff<br />
This is the second of two residential workshops for 2016 and will inform delegates of both BSAC & EUCAST<br />
standardised disc testing methods and give an overview of other susceptibility testing methods. Delegates will be<br />
given an understanding of how to test difficult organisms and how to solve susceptibility testing problems. There are<br />
20 delegates on each course, plus faculty.<br />
Date to be confirmed, September 2016, Public Debate on AMR - Public Health England, University of Manchester,<br />
Second public event to raise awareness of the problems associated with antimicrobial resistance (AMR)<br />
12 October 2016, BSAC Susceptibility Testing User Training Days, London and Manchester<br />
To complement the Societies Susceptibility Testing programme, we will be running two training days in 2016 for<br />
users of the method and to offer guidance on the move to EUCAST. Programme has been agreed, the meeting has<br />
been promoted and registrations are beginning to come in.<br />
October 2016, Proposed Symposium at ID Week<br />
To note this joint BSAC / DRIVE-AB symposium was not accepted.<br />
October – December, BSAC/BIA/HIS Regional Educational Workshops 2016, Multi Drug Resistant Gram Negative<br />
Infections<br />
10 events will be held at 9 venues across the UK. Costs are shared between BSAC, HIS and BIA. Sponsorship from a<br />
pharmaceutical company is in final stages of discussion.<br />
Location Venue Date<br />
Dublin Gibson Hotel 26 October<br />
North West Conference Centre, Aintree University Hospital W/C 31 Oct, tbc<br />
Edinburgh Royal College of Physicians W/C 31 Oct, tbc<br />
Salisbury Salisbury Racecourse 1 November<br />
London Wellcome Collection Conference Centre 1 November<br />
North East Life Conference and Banqueting 4 November<br />
Leeds Radisson Blu Hotel 8 November, tbc<br />
Cardiff All Nations Centre 10 November, tbc<br />
Birmingham Birmingham University 14 November<br />
6 – 8 November, FIS/HIS 2016 Edinburgh<br />
BSAC sessions are now confirmed as follows:<br />
21
Monday 7 November. 09:00-10:00 - PLENARY SESSION<br />
Therapeutic and technological advances in infection management (BSAC Plenary)<br />
What’s new in drugs for infection – is help around the corner, Robin Howe<br />
Can new diagnostic technologies help infection prevention and management? Estee Torok<br />
Monday 7 November, 10:45-11:15 - PARALLEL SESSION<br />
BSAC Antibacterial resistance in the British Isles Update for 2016<br />
Resistance Epidemiology Update: new and old friends, David Livermore<br />
Resistance Data on newly approved anti-bacteria’s, Alasdair MacGowan<br />
Stewardship issues related to rising resistance and new agents, Hayley Wickens<br />
Tuesday 8 November, 13:30-15:00 - PARALLEL SESSION<br />
Driving better prescribing: challenging the norms<br />
National sentinel surveillance programmes: too much of a luxury or essential? Alasdair MacGowan<br />
Is behavioural science the real driver for improving effective antimicrobial prescribing? Peter Davey<br />
Novel educational solutions to drive better prescribing- evidence of effectiveness? Dilip Nathwani<br />
2016 ARM Conference, 24-25 November 2016, Holiday Inn Birmingham, UK<br />
07 December 2016, Locally Administered Antimicrobials, Royal College of Physicians London, UK<br />
8 – 9 December 2016, OPAT Meeting, International Convention Centre Birmingham, UK<br />
14 March 2017, BSAC Spring Conference: The Global Challenge of MDR GNB Infections, QEII Centre, London<br />
The 2017 Spring Conference will be held in collaboration with the Healthcare Infection Society and will promote,<br />
amongst other topics and presentations, the joint BSAC-HIS guideline on MDR Infections. It is proposed that the<br />
meeting is used as a platform for the launch of a PHE target initiative to reduce MDR infections, possibly introduced<br />
by the Secretary of State for Health. Final confirmation of arrangements is awaited from ARHAI. BSAC is keen that<br />
the meeting retains its global perspective in addition to providing a platform for what will be a national initiative.<br />
8-9 June 2017, European Vaccines and Diagnostics Summit, ICC, Birmingham UK<br />
2 day conference: Prevention and rapid detection of infection: the essential role of vaccines and diagnostics in<br />
improving public health and/or reducing resistance.<br />
Outputs from this conference will include 2 virtual learning modules – vaccines and the role of the laboratory in<br />
stewardship and surveillance.<br />
30 November – 01 December 2017, Federation of Infection Societies, International Convention Centre, Birmingham<br />
Venue secured, faculty to be called together for first discussions June 2016.<br />
Brendan Healy<br />
Meetings Secretary<br />
July 2016<br />
22
ANTIBIOTIC ACTION and other PUBLIC ENGAGEMENT ACTIVITIES<br />
A document for <strong>Council</strong> to consider<br />
Since 7 th April until 23 rd June 2016, Antibiotic Action has been involved in numerous activities including<br />
publications, responding to media enquiries presenting and/or attending meetings and conferences. Full details can<br />
be found in appendices 1-2.<br />
Appendix 1: summary of Antibiotic Action activities from 7 th April to 23 rd June 2016. It reports on progress and<br />
is for information only.<br />
Appendix 2: Questions raised in Parliament on Antibiotics April - June 2016<br />
Action requested: Questions for APPG members to ask in Parliament.<br />
Hayleah Pickford (intern 1 st April – 1 July 2016) has collated information on how to measure the impact of<br />
grant funding. With Laura Piddock, she has written a report for The BSAC Executive Committee including<br />
recommendations as to how to implement measuring the impact of BSAC grant funding.<br />
Hayleah has also collated information on how to measure the impact of other charitable activities such as public<br />
engagement. With LJVP, she has measured the impact of Antibiotic Action and a report for the BSAC Executive<br />
Committee is in preparation. It is hoped to submit this by 31 July 2016.<br />
23
Appendix 1 Antibiotic Action Activities since 7 April to 23 June 2016<br />
Fundraising<br />
<br />
Nothing to report.<br />
All-Party Parliamentary Group on Antibiotics (APPG-A)<br />
<br />
<br />
<br />
<br />
The Annual General Meeting of APPG-A was held on Wednesday on 8 th June 2016. Officers elected were:<br />
Julian Sturdy MP – Chair; Countess of Mar – Co-Chair ; Kevin Barron MP – Secretary; Baroness Masham of<br />
Ilton – Treasurer<br />
Re-registration of the APPG-A.<br />
The APPG-A has welcomed a new member to the group, Mr Kevin Holinrake MP (Con).<br />
The APPG-A is planning 2-3 meetingtsg in 2016-17. The first is a joint meeting with the All Party Health<br />
Group on The Pharmaceutical Industry. The proposed title is ‘Funding of discovery, research and development<br />
of new antibacterial treatments’. This meeting is to be a follow-up to the AMR Review report and<br />
recommendations with a presentation from the EU IMI funded project DRIVE-AB reporting their interim<br />
findings on potential economic models for stimulating drug development.<br />
Website<br />
<br />
Annual review of the Antibiotic Action website took place in May. Minor revisions to several pages including<br />
the homepage were made.<br />
AA Meetings and Conference Presentations<br />
<br />
<br />
<br />
<br />
All4Us Roundtable meeting, 19 th May 2016, London.<br />
DRIVE-AB Conference,2-3 June 2016, Amsterdam.<br />
The Ticking Time Bomb of Antimicrobial Resistance: What can we do and where should we go next? 8 th June<br />
2016, Edinburgh. (TB)<br />
Invited to speak at the Annual Research Meeting for Military Medicine, 8 th Dec 2016, London, LJVP (April).<br />
<br />
<br />
<br />
<br />
Forthcoming:<br />
Plugging the Antibiotics Gap: A Medicinal Chemist’s Perspective, 16 th November 2016, Cheshire. (LJVP).<br />
ARM 2016 (LJVP, deputy Chair_<br />
EVID, 8-9 June 2017, Birmingham<br />
Public Engagement<br />
<br />
<br />
<br />
‘Turn your nose up’ campaign with the Farms not Factories organisation, (May)<br />
Bridging The Gap, 9 th June Warwick University, (VW)<br />
Invited to part in the panel ‘Developing New Business Models and Regulatory Frameworks to Facilitate Drug<br />
Discovery’, Policy-UK Antimicrobial Resistance Forum, 15 th June 2016, London. (April)<br />
24
Took part in a written panel interview which will appear in Future Medicinal Chemistry’s upcoming New<br />
Frontiers in Antimicrobial Drug Discovery special issue, guest edited by Mark Moloney, University of Oxford,<br />
UK (April 2016.<br />
Interviewed by Bloomberg News, Australia, LJVP (April).<br />
Invited to speak at an education session for Public Health registrars, Yorkshire, LJVP (April).<br />
Invited to interview with The Naked Scientist, LJVP, (April).<br />
Discussions with John Tearle from Flix Interactive about a Wellcome Trust funded project on an antimicrobial<br />
resistance computer game, LJVP, (April).<br />
APPG on Antibiotics Meeting The Review on Antimicrobial Resistance and how the NHS and Pharmaceutical<br />
industry are responding to the UK Strategy on AMR, 4 th May 2016, LJVP, NB, VW (May).<br />
Release of BSAC policies on antimicrobial use in animals and humans (May).<br />
Interviewed by The Atlantic on the O’Neill Report, LJVP, (May).<br />
Interviewed by BBC Radio 4 Today programme (1:22), LJVP (May).<br />
Interviewed by BBC2 Victoria Derbyshire programme (May).<br />
Interviewed by BBC Radio 4 Today programme (2:25) LJVP, (May).<br />
Interviewed by BBC World on superbugs, LJVP, (May).<br />
Invited to interview by Good Morning Britain about the O’Neill Report, LJVP, (May)<br />
Interviewed by Kevin Fong, National Geographic, LJVP (May).<br />
Interviewed by Bang! Oxford University’s Science Magazine, LJVP (May).<br />
Interviewed by a 7 th grader for a project on antibiotic resistance, LJVP (May).<br />
Interviewed by the Daily Mail Good Health, LJVP (May).<br />
Provided comment to Science Media Centre on colistin-resistant bacteria in US woman, LJVP (May).<br />
Invited to attend the UK premier of the documentary “Clean Hands”, 28 th June, London, LJVP (May).<br />
Invited to interview by The Los Angeles Times, LJVP (June).<br />
BBC Radio 4 ‘In our Time’ programme, Penicillin, 9 th June 2016, LJVP (June).<br />
Invited to interview by “Sputnik – Orbiting the World with George Galloway”, LJVP (June)<br />
Invited to write an article for The Conversation, LJVP (June).<br />
Reviewed and edited the script for a cartoon series generated by the Dundee Design School, LJVP (June).<br />
Invited to write an article for the Spanish newspaper ‘El País, LJVP (June).<br />
Provided a quote to the British Medical Journal for a feature on the impact of NICE sepsis guidance on antibiotic<br />
subscribing, LJVP (June).<br />
Attended the Longitude Prize Advisory panel meeting to review applications, LJVP (June).<br />
Invited to present a keynote lecture at the Aquaculture conference, October 2016, Inverness, LJVP (June).<br />
Invited to participate on a review panel, Academy of Finland, 7 th February 2017, LJVP (June).<br />
Invited to speak at the Sepsis Unplugged Conference, 13-14 October 2016, LJVP (June).<br />
Funded projects with others<br />
DRIVE-AB:<br />
25
Attending the 4th stakeholder meeting for the realist review on antimicrobial prescribing for doctors-intraining,<br />
17 th June, University of Exeter, PH (June).<br />
Grant applications on which antibiotic action/BSAC are Co-applicants or partners<br />
<br />
<br />
Flix Interactive Antimicrobial Resistance game –Wellcome Trust have funded pilot study.<br />
Antibiotic resistant bacteria film, Jack Levy and Two Halves Pictures – applying to the Wellcome Trust for<br />
funding<br />
Department of Health and CMO - Provided the CMO with slides to be used at International meetings.<br />
Publications<br />
Reflecting on the final report of the O’Neill Review on Antimicrobial Resistance. LID, May 2016<br />
Ask the Experts: how to curb antibiotic resistance and plug the antibiotics gap? Future Medicinal Chemistry,<br />
June 2016<br />
AA Champions<br />
To date there are 138 Champions from 25 countries (83 UK, 24 EU, 26 rest of the world). To help deliver the aims<br />
of Antibiotic Action, Champions are asked to promote Antibiotic Action by:<br />
<br />
<br />
engaging with peer groups to raise awareness e.g. giving lectures, putting up posters, engaging with the media.<br />
using social media AA Champion FaceBook page, Twitter) to inform others of activities.<br />
AA Stakeholders (previously called Petitioners and Partners)<br />
The 'Antibiotics in Modern Medicine' posters were sent out to 26 charities (Cystic Fibrosis, Diabetes, Pre-term infant,<br />
UTI, Joint replacement and Cancer). To date 3 charities have responded (Butterfly Trust (CF), The Cystitis and<br />
Overactive Bladder (COB) Foundation, and the Independent Diabetes Trust) with requests for more posters or the<br />
Antibiotic Action logo to use in newsletters.<br />
AA Intern<br />
Reviewing CVs of potential interns from the Computer Sciences Department, University of Birmingham. Their<br />
project will be to turn the excel database created by previous interns (Luchi Farrell, Rebecca Lo and Joe<br />
Wanford) into a searchable database accessible by all via ARC.<br />
Antibiotic Action Advisory Board<br />
<br />
Next meeting 1 st November.<br />
Working with other organisations - Nothing new to report.<br />
-End-<br />
26
15HLT07 AntiMicroResis - Kick Off Meeting<br />
23 rd June, 2016, Twickenham – London<br />
A document for <strong>Council</strong> to note<br />
BSAC is an academic partner in this EURAMET Grant running from June 2016 - May 2019.<br />
EURAMET is an EU funding body which supports research in measurement and standardisation. Historically, this<br />
funding has gone into physics and chemistry but increasingly biology. The lead organisation is LCG from the UK<br />
but there are partners from France, Germany, Spain and Slovenia. As with such EU grants, there are several<br />
experimental work packages, a management work package and dissemination work package. The BSAC role seems<br />
to be providing relevant expertise to support the experimental work packages through its Standing Committees and<br />
Working Parties and perhaps, more important, knowledge transfer via its publications, meetings and educational<br />
activities. The experimental work packages focus on standardisation of source materials for procalatonin testing,<br />
standardisation and EQA of genetic tests for pathogen identification and susceptibility testing, standardisation of<br />
cellular assays - for example, MIC testing, standardisation and EQA of viral load testing and resistance detection by<br />
PCR, development of reference standards to screen membrane active developmental antimicrobial using artificial<br />
bacterial cell membranes and investigation of future methods to detect antimicrobial resistance, namely MALDI-<br />
TOF and WGS.<br />
There are likely to be 6 meetings up to 2019. The exact role of BSAC is not yet determined.<br />
A P MacGowan<br />
23 rd June, 2016<br />
27
British Society for Antimicrobial Chemotherapy<br />
Unconfirmed minutes of the BSAC Publications Committee<br />
held on Wednesday 20 April 2016<br />
Present:<br />
Conor Jamieson, Honorary Treasurer<br />
Peter Donnelly, Editor-in-Chief<br />
Colin Drummond, Editorial Manager<br />
Phil Bishop, OUP<br />
Laura Orchard, OUP<br />
Apologies:<br />
Kate Gould, General Secretary<br />
Clare Jeeves, Senior Staff Editor<br />
Dilip Nathwani OBE, President<br />
Tracey Guise, Chief Executive Officer<br />
PC/16/01<br />
Welcome and apologies for absence<br />
The Chair welcomed members to the meeting. Apologies for absence were NOTED.<br />
PC/16/02<br />
Minutes of the last meeting<br />
The unconfirmed minutes of the meeting held on 5 July 2015 were APPROVED as a true record of<br />
the meeting.<br />
PC/16/03<br />
Matters arising<br />
PC/16/04<br />
Editorial Board<br />
The Editor in Chief reported that Leonard Leibovici is about to step down as Senior Editor to take up<br />
the E-i-C position for CMI, in addition David Reeves will commence a leave of absence for personal<br />
reasons. He has made a number of appointments. Publications Committee:<br />
(a)<br />
SUPPORTED the appointment of the following:<br />
Senior editors: John Perry, Engeline Van Duijkeren and Athanassios Tsakris.<br />
Editors: Diane Ashiru-Oredope, Russell Lewis, David Van Duin, Sally Partridge, Anouk<br />
Muller and David Jenkins.<br />
(b)<br />
NOTED that the geographical distribution of Editors (19UK; 8 USA; remainder Europe) was<br />
in slight contrast with usage and author distribution data, with 36% of usage being in the<br />
USA.<br />
(c)<br />
AGREED consideration will be given to the appointment of additional editors within the<br />
USA, particularly the appointment of senior bacterial Editor from the USA.<br />
28
(d)<br />
Gave SUPPORT in principle to a proposal that OUP offers a 3-4 hour compact Oxfords<br />
Journal Day for senior members of BSAC team (President, Treasurer, CEO) with edited<br />
highlights of development areas in publishing. Phil Bishop will formally propose and<br />
organise.<br />
PC/16/05<br />
Journal finances - subscription income and accounts<br />
Publications Committee:<br />
(a)<br />
CONSIDERED the accounts for the financial year ended 31 December 2015 and budget for<br />
the year ending 31 December 2016, discussing the reasons for changes in consortia income<br />
(a loss of 70 institutions during 2015), supplement revenue (£60k lower than in 2014),<br />
approval process for agreeing changes to open access charges to authors and perceived<br />
anomalies in the 2016 budget.<br />
(b)<br />
NOTED the following points arising:<br />
OUP has not performed as well in securing consortia subscription, which replace<br />
traditional institutional subscriptions, as they had hoped. Consortia subscriptions are<br />
intended to preserve the subscription base of the journal.<br />
A number of large country based consortia did not renew in 2015 (about 23K of<br />
income).<br />
OUP has a relatively large international sales force who will be attempting to sell JAC<br />
into new markets as it is a well-established journal.<br />
Open access income is still relatively low.<br />
Supplement revenue also fell by 60K in 2015 compared with 2014.<br />
Overall it is considered that a number of streams combined to result in a decline in the<br />
overall income. OUP’s belief is not that this is a trend; it should be more of a one off<br />
incident.<br />
(c)<br />
AGREED the following:<br />
Changes to open access charges are an operational matter and do not require formal<br />
approval from BSAC; advance notice only required.<br />
Phil Bishop will review and report back to BSAC on questions arising from consideration<br />
of the budget including copy-editing charges (increase from 22K to 52K), type-setter<br />
charges and changes to budget convention.<br />
PC/16/06<br />
Journal strategy<br />
Publications Committee:<br />
29
(a)<br />
CONSIDERED a number of strategic aspects of Journal organisation and management,<br />
including changes to senior editors and editors, the effect the aims and scope of JAC<br />
introduced in January 2016 had had in reducing unwanted submissions, revised<br />
instructions to authors and staffing support for the BSAC editorial office.<br />
(b)<br />
AGREED to recommend that BSAC increases OUP virtual office provision, provided by Sadie<br />
Thrift, from 40-80 hours per month. Final approval will be subject to receipt of an<br />
inventory detailing how the current 40 hours are used to assist the Editorial Manager in<br />
planning how virtual office support is used going forward.<br />
(c)<br />
NOTED the maximum cost would be £15,000 pa for 80 hours support but was an economic<br />
and viable solution that avoided the cost of an appointment of a full time member of staff at<br />
the office which would include tax, NIC, pension and on-costs.<br />
PC/16/07<br />
40 th Anniversary Articles<br />
The Editor in Chief reported that he has commissioned a series of ‘Behind the Scenes’ articles from<br />
JAC Editorial Office, BSAC and OUP. All anniversary articles will appear collectively in a virtual<br />
issue at the end of 2016. The Editor in Chief is aware of several articles that are in preparation and<br />
is actively engaged with authors to ensure these are produced and submitted in a timely fashion.<br />
It was NOTED that OUP has developed an interactive timeline that is available from the Journal<br />
website and also from the BSAC website. This timeline links through to free articles and listed<br />
important landmarks in JAC’s 40 year history.<br />
PC/16/08<br />
Supplements planning and process<br />
Members NOTED the following in relation to JAC supplements in development or commissioning<br />
stages:<br />
(a) SOAR Supplement - published online 05 April 2016.<br />
<br />
<br />
<br />
<br />
<br />
<br />
(b) Supplements in the pipeline<br />
OPAT – will now be a series of Leading articles<br />
CARE pathway Supplement (submission around 01 July)<br />
Tetraphase Supplement (now delayed awaiting FDA moves on the drug)<br />
CEMPRA Solithromycin Supplement (Glenn Tillotson, now wrestling with what the regulatory guys will<br />
allow in a Supplement, much reduced from the old days)<br />
Clostridium difficile Supplement (potentially from Mark Wilcox at ECCMID)<br />
Basilea (Invasive Mould infections)<br />
30
PC/16/09<br />
Editorial meetings<br />
The Committee reviewed the format and regularity of editorial meetings, noting that two<br />
teleconferences held in December 2016 had led to engagement with 20 editors and productive<br />
discussions.<br />
The editorial team meets with OUP in the Netherlands four times each year, with senior editor<br />
meetings held twice yearly, one in person meeting and one virtual meeting.<br />
PC/16/10<br />
Journal metrics<br />
The Editorial Manager presented a report outlining key metrics in relation to Journal production.<br />
The following points arising were NOTED:<br />
(a)<br />
(b)<br />
(c)<br />
(d)<br />
There are some problems in securing reports and decision in a timely fashion from a small<br />
number of editors. This is being addressed as is the need to maintain an increase in<br />
immediate rejections based on the aims and scope of the Journal.<br />
Development of a scatter plot of Editor performance charts the number of articles handled<br />
against speed of handling. This helps us identify Editors who are dealing with low numbers<br />
of articles slowly. Steps are being taken to address this as it can cause operational problems<br />
and result in author queries.<br />
Data appears to show that the 7% of immediate rejections that the Editor in Chief was able<br />
to reject last year has now proved impossible and has moved directly over in the accepted<br />
sector. The Senior Editor immediate rejections and Editor rejections have remained the same.<br />
An improved focus on increasing rejections at all stages is needed.<br />
Post acceptance handling times have been creeping up over the past year. This is now a very<br />
serious focus and both sides are committed to bringing this back down. The increased<br />
number of revision decisions and acceptances unfortunately impacts on this and is likely to<br />
cause delays as both the copy editors and JAC EO staff will struggle if there is too much<br />
accepted material moving through the system. Both BSAC and OUP will monitor, review and<br />
address as required.<br />
PC/16/11<br />
JAC budget submission<br />
It was NOTED that the budget submission for internal BSAC editorial costs needs to be submitted to<br />
the Honorary Treasurer by Friday 1 July 2016<br />
31
PC/16/12<br />
Publishers report, including marketing report<br />
Phil Bishop and Laura Orchard presented the publishers report and marketing report. The<br />
following matters arising were NOTED:<br />
(a) Data demonstrated that mean acceptance time to publication in 2015 was 4.5 weeks with<br />
responses from author surveys being favourable, borne out by a lack of complaints received<br />
post-acceptable by the BSAC editorial office.<br />
(b) OUP projections suggest that the Impact Factor this year will be on the edge of 5.0 but it was<br />
agreed it would be preferable if JAC did not fall below 5.0. It was agreed that CMI should<br />
be included on the IF slide by OUP for future reports.<br />
(c) There has been a slight increase in monthly downloads (1.6%).<br />
(d) The establishment of the supplements working group and the alteration of the Aims and<br />
Scope were good progress for the Journal.<br />
(e) Marketing objectives for 2016 are to increase usage by 5% and exposure of the journal<br />
through conference presence and social media activities and to continue to support the<br />
Editorial team in obtaining high quality submissions for JAC.<br />
(f) The Editor in Chief will request more help from BSAC with ‘boots on the ground’ at key<br />
meetings and people talking to high quality authors and encouraging them to submit to JAC<br />
(he cited the example of John McConnell at Lancet Infectious Diseases who spends a lot of<br />
time making the right contacts at meetings).<br />
PC/16/13<br />
Websites<br />
It was NOTED that the BSAC has the following websites that promotes its initiatives and activities:<br />
www.bsac.org.uk<br />
BSAC main website, currently under review<br />
www.antibiotic-action.com Antibiotic Action, due for relaunch September 2015<br />
www.e-opat.com<br />
UK OPAT Initiative<br />
www.res-surv.org Resistance Surveillance, relaunched in 2014<br />
www.nas-pps.com<br />
Placeholder website for the forthcoming Point Prevalence Survey<br />
system; will be developed to full site for launch<br />
www.appg-on-antibitoics All Party Parliamentary Group on Antibiotics<br />
http://jac.oxfordjournals.org/ - JAC, managed by OUP<br />
www.futurelearn.com/courses/antimicrobial-stewardship -<br />
managed by FutureLearn for Massive Open Online Course on Antimicrobial Stewardship<br />
PC/16/14<br />
Any other business<br />
PC/14/14a<br />
DeepDyve<br />
32
It was AGREED that OUP will formally propose that JAC formally subscribe to DeepDyve, an article<br />
rental service where users can hire access to an article. It would represent a little extra income with<br />
no apparent damage to other streams evident from experience with other OUP journals.<br />
OUP will monitor other streams and would pull out if there was a steep decrease in related income<br />
streams. It was NOTED that comparator journals JCM and CMI are both in DeepDyve.<br />
PC/14/14g<br />
JAC Pricing<br />
It was AGREED to recommend to BSAC <strong>Council</strong> that a 5% price increase in the institutional<br />
subscription price as advised by OUP is approved. Phil Bishop will provide a paper for <strong>Council</strong><br />
giving a justification for this recommended increase.<br />
Signed:<br />
…………………………………………………………………….<br />
Date:<br />
…………………………………………………………………….<br />
33
BSAC Guideline Development and Guideline Working Groups<br />
A document for <strong>Council</strong> to consider<br />
This document outlines the guidelines working and development groups current in session. It reports on current<br />
position and progress and is for information only. Where a decision on working group progress is required, this is<br />
indicated both on the <strong>agenda</strong> and below.<br />
1 BSAC / Vascular Society Vascular Graft Infections Guideline Working Group<br />
Lead: Jon Sandoe (BSAC lead) & Rachel Bell (Vascular Society lead) and Nick Price.<br />
Literature review and data extraction is on-going. Currently only three papers have met inclusion criteria.<br />
Plan to write-up literature search and then identify suitable individuals willing to sit on a panel for<br />
development of a guideline based on expert opinion.<br />
2 BSAC, HIS, IPS and BIA MRSA Guideline Working Group<br />
Overall Lead: Irwin Brown . BSAC Lead: Nick Brown<br />
A joint group comprising representation from BSAC, HIS, BIA and IPS has been established to consider<br />
updating the joint BSAC, HIS, ICNA MRSA guidance published 2005/6/8. BSAC will be working with BIA on<br />
treatment and management whilst HIS and IPS will be taking diagnosis, screening, infection prevention and<br />
control aspects forward. Following agreement on the guideline finances literature search and review is<br />
anticipated to begin in early May.<br />
3 BSAC, HIS, BIA Joint Guideline Development Group on MDR Gram Negative Infections<br />
Chairs: Peter Hawkey and Peter Wilson<br />
The infection control paper was published in JHI in November. The diagnosis and treatment paper has just<br />
completed a process of national consultation and is being finalised for submission.<br />
4 Therapeutic Monitoring Literature Review Group<br />
Chair: Nick Brown. Authors: Abi Jenkins, Alison Thomson, Yvonne Semple, Nick Brown, Christine Sluman,<br />
Alastair MacGowan, Andrew Lovering and Phil Wiffen<br />
Details of the literature review were presented at the BSAC Spring Meeting and the survey as a poster at<br />
ECCMID. A Guideline development meeting (expert opinion) was held in May.<br />
34
5 OPAT: Oral Agents in the OPAT Setting<br />
Lead: Matthew Dryden<br />
Literature search complete and intend to write-up finding for submission to JAC in the autumn.<br />
6 Endocarditis<br />
BSAC guidelines were published in 2011 and following update of guidance produced by other<br />
organisations we aim to update the literature search and review in June 2016. New evidence will be<br />
submitted to the authors for review and consideration of a guideline update.<br />
General Secretary<br />
June 2016<br />
35
Minutes for BSAC Grants Committee Meeting<br />
Wednesday 11 May 2016 (BSAC HQ)<br />
Committee members present:<br />
In attendance:<br />
Apologies:<br />
Dr Paul Long, Grants Secretary<br />
Dr Colin Sutherland<br />
Dr Estée Tӧrӧk<br />
Dr Robin May<br />
Dr Keith Miller<br />
Dr Felicity Drummond<br />
Ms Debbie Foster<br />
Professor Kate Gould<br />
G/2016/01<br />
Welcome and apologies for absence<br />
The Chair welcomes members to the meeting, Apologies for absence were NOTED:<br />
G/2016/02<br />
Minutes of the last meeting<br />
The unconfirmed minutes of the committee meeting held on 15 May 2015 were APPROVED as a<br />
true record of the meeting<br />
GC/2016/03<br />
Funding available for 2016 awards<br />
It was NOTED that £140,000 is available to the BSAC grant funding programme. No PhD<br />
studentship applications were invited for this round of funding.<br />
The following applications were received by grant type:<br />
Summary of 2016 Grant Applications<br />
Grant Type No. of applications Total value of applications<br />
Research 109 £3,760,228<br />
Project 51 £679,404<br />
Vacation 12 £23,280<br />
Overseas 7 £81,898<br />
Travel - ECCMID 9 £7,111<br />
Travel - ASM Microbe 8 £12,401<br />
Travel - Terry Hennessey 3 £4,261<br />
Education 0 NA<br />
PhD Studentship 0 NA<br />
TOTAL 199 £4,568,583<br />
36
GC/2016/04<br />
Research Grant Applications<br />
The following Research grants were RECOMMENDED for funding:<br />
GA2016_012R Fabrice Boyom. University of Yaoundé I, Yaoundé, Cameroon. £50,000<br />
GA2016_087R Simone Brogi. University of Siena, Siena Italy. £21,000<br />
Details of all other applications not recommended for funding are held at the BSAC office.<br />
GC/2016/05<br />
Project Grant Applications<br />
The following Project grants were RECOMMENDED for funding:<br />
GA2016_009P Brian Robertson. Imperial College London, UK. £15,000<br />
GA2016_020P Françoise Debierre-Grockiego. Université Francois-Rabelais tours, France. £15,000<br />
GA2016_029P Martin Scanlon. Monash University, ViC, Australia. £15,000<br />
Details of all other applications not recommended for funding are held at the BSAC office.<br />
GC/2016/06<br />
Vacation Grant Applications<br />
The following Vacation grants were RECOMMENDED for funding:<br />
GA2016_002V Cecilia Cabrera. University of Strathclyde, UK. £2,300<br />
GA2016_006V Jordan Au. University of Leeds, UK. £1,220<br />
GA2016_011V Clarice Kayee Chu. University of Leicester, UK. £1,940<br />
Details of all other applications not recommended for funding are held at the BSAC office.<br />
GC/2016/07<br />
Overseas Scholarship Applications<br />
The following Overseas Scholarship was RECOMMENDED for funding:<br />
GA2016_005OS UK Sponsor: Rebecca Goss, St Andrews £11,800<br />
Details of all other applications not recommended for funding are held at the BSAC office.<br />
GC/2016/07<br />
Travel Grant Applications Awarded<br />
37
GC/2016/07a ECCMID<br />
The following ECCMID Travel grants were RECOMMENDED for funding:<br />
GA2016_005T Gereltuya Dorj. Mongolian National University, Mongolia. £1,000<br />
The assessment of the implementation of the national strategy on antimicrobial resistance and<br />
rational use of antibiotics in Mongolia [Full report received]<br />
GA2016_007T Ayham Abulaila. Kağıthane – Istanbul, Turkey. £753.40<br />
Comparison of a novel OXA-48 K-SeT test and Blue-Carba test in detection of Carbapenemaseproducing<br />
Enterobacteriaceae with using PCR as reference method [Full report received]<br />
Details of all other applications not recommended for funding are held at the BSAC office.<br />
GC/2016/07b Travel Grant Applications Awarded – ASM Microbe<br />
The following ASM Microbe grant was RECOMMENDED for funding:<br />
GA2016_018T Juliana Alcoforado Diniz. University of Dundee, Scotland. £1,128<br />
Details of all other applications not recommended for funding are held at the BSAC office.<br />
GC/2016/07a Terry Hennessey Fellowship<br />
The following Terry Hennessey grant was RECOMMENDED for funding:<br />
GA2016_011T Nicole Stoesser. University of Oxford, UK. £1,280<br />
Details of all other applications not recommended for funding are held at the BSAC office.<br />
GC/2016/08<br />
Summary of 2016 Grant Awards made<br />
GRANTS AWARDED 2016<br />
SUMMARY OF GRANTS RECEIVED, FUNDING AVAILABLE AND FUNDING AWARDED<br />
Total number of grant applications received: 199<br />
Total funding requested: £4,568,583<br />
Total funding available: £140,000<br />
Total number of grants awarded: 12<br />
Total funding awarded: £136,141.40<br />
38
Grant Type Grant No. Lead Applicant / Country Amount (GBP)<br />
Candidate<br />
Research GA2016_012R Fabrice Boyom Cameroon £50,000.00<br />
Research GA2016_087R Simone Brogi Siena, Italy £21,000.00<br />
Project GA2016_009P Brian Robertson London, UK £15,000.00<br />
Project GA2016_020P Françoise France £15,000.00<br />
Debierre-<br />
Grockiego<br />
Project GA2016_029P Martin Scanlon Australia £15,000.00<br />
Vacation GA2016_002V Cecilia Cabrera Strathclyde, £2,300.00<br />
Scholarship<br />
(candidate) UK<br />
Vacation GA2016_006V Jordan Au Leeds, UK £1,220.00<br />
Scholarship<br />
(candidate)<br />
Vacation GA2016_011V Clarice Kayee Leicester, £1,940.00<br />
Scholarship<br />
Chu (candidate) UK<br />
Travel -<br />
ECCMID<br />
GA2016_005T Gereltuya Dorj Mongolia £1,000.00<br />
Travel -<br />
ECCMID<br />
Travel - ASM<br />
Microbe<br />
Overseas<br />
Scholarship<br />
Terry<br />
Hennessey<br />
Fellowship<br />
GA2016_007T Ayham Abulaila Turkey £753.40<br />
GA2016_018T Juliana<br />
Scotland £1,128.00<br />
Alcoforado Diniz<br />
GA2016_005OS Rebecca Goss Scotland £11,800.00<br />
GA2016_011T Nicole Stoesser Oxford, UK £1,280<br />
GC/2016/09<br />
Any other business<br />
GC/2016/09a Grants Processes<br />
Members NOTED that BSAC is implementing an online system (Scholar One) for managing the<br />
grants process. The purpose of the new system is to automate, as far as possible, the grants process.<br />
The system and processes will include the following:<br />
(a)<br />
An application submission open date of 1 September with close date of 1 November<br />
39
(b)<br />
(c)<br />
Introduction of an initial screening step to ensure all applications fulfils BSAC requirements/<br />
are competitive (extending to project, research, PhD studentship & Education grants) which<br />
will be carried out by the Grants Secretary.<br />
Triage review conducted by the Grants Secretary (with committee assistance as required).<br />
[Since the committee met this step was removed from the process as not possible to<br />
accommodate within the online platform]<br />
Paul Long, Keith Miller & Colin Sutherland indicated interest / support for testing implementation of<br />
the system.<br />
GC/2016/09b Eligibility criteria<br />
BSAC <strong>Council</strong> has approved amendments to the eligibility criteria for grant applicants. The new<br />
criteria read as follows:<br />
“BSAC encourages applications on topics consistent with the strategy of this Society, and from early<br />
career researchers and clinical trainees. Furthermore, we support proof of principle research<br />
projects which will facilitate applications to other funding agencies. Please note that we do not<br />
encourage applications from those individuals who have been in receipt of total research funding of<br />
more than £100,000 (or equivalent currency of applicant’s country) in the last 2 years.<br />
Each year, BSAC typically awards 1- 2 grants of £50,000 per project (large grant) and 2-3 smaller<br />
grants of £15,000 per project. Due to the large number of applications received by BSAC, there is a<br />
triage process where the eligibility of applicants and topic of Application is assessed. Applications<br />
that do not meet these eligibility criteria will be rejected.”<br />
Some members were concerned that this change might reduce the quality of applications submitted;<br />
noting any concerns or proposals for changes would need to be presented to the next meeting of<br />
<strong>Council</strong> on 7 July 2016.<br />
GC/2016/09c Extending PhD studentships to include other awards<br />
Members NOTED that BSAC <strong>Council</strong> had approved a proposal for, from the 2016 call onwards, the<br />
definition of studentship to be broadened beyond PhD studentships to include research training<br />
leading to other equivalent awards e.g. Pharm D, MD, DDS. Funding for a maximum of £25,000pa<br />
for a maximum of four years will remain unchanged.<br />
GC/2016/09b Focussed calls for BSAC grant applications<br />
The Committee:<br />
40
(a) NOTED that BSAC <strong>Council</strong> has agreed to call for Research grants (i.e. Project, Research &<br />
Studentships) in specific areas aligned more closely to the priorities and activities of the Society.<br />
A short list of topics is currently being considered.<br />
(b) Expressed concern that this might reduce the number of quality applications submitted; noting<br />
any concerns or proposals for changes would need to be presented to the next meeting of<br />
<strong>Council</strong> on 7 July 2016.<br />
GC/2016/09c Membership<br />
It was NOTED that:<br />
(a) The terms of office of Robin May & Estee Torok have come to an end.<br />
(b) The Grants Secretary will consider and propose candidates to replace Robin May; Estee orok<br />
will consider whether to serve a second term of office.<br />
(c) The Grants Secretary is considering increasing the number of committee members from 6 –<br />
8.<br />
Signed ………………………………………………………………..<br />
Date ……………………………………………………………………<br />
- End -<br />
41
APPLICATIONS FOR MEMBERSHIP<br />
A document for <strong>Council</strong> to consider and approve<br />
7 applications for Membership of the BSAC have been received since the last meeting of <strong>Council</strong>. All applicants<br />
submitted supporting statements which have been seen and verified by the General Secretary.<br />
APPLICANTS<br />
Miss Kerry Nanji, Medical Science Liaison Specialist, Quintiles<br />
Mrs Raquel Portela, PhD Student, Universidade Nova de Lisboa (UNL)<br />
Ms Catia Marques, PhD Student, University of Lisbon<br />
Dr Constanca Pomba, Associate Professor, University of Lisbon<br />
Dr Daiana Lima-Morales, Post Doctoral, HCPA<br />
Miss Lindsay Ferguson, PhD Student, University of The West of Scotland<br />
Mr Steve Millington, Sales/Marketing Business Development, Optigene<br />
Current membership numbers:<br />
Total 791<br />
Ordinary Members 651<br />
Retired Members 111<br />
Honorary Members 29<br />
July 2016<br />
42